Reuters logo
BRIEF-Zealand Pharma partner starts Phase 1 trials for two novel treatments
August 22, 2017 / 1:57 PM / a month ago

BRIEF-Zealand Pharma partner starts Phase 1 trials for two novel treatments

Aug 22 (Reuters) - ZEALAND PHARMA A/S:

* PHASE 1 TRIALS FOR TWO NOVEL TREATMENTS OF OBESITY AND/OR DIABETES INITIATED BY ZEALAND PARTNER BOEHRINGER INGELHEIM

* ZEALAND TO RECEIVE A EUR 4 MILLION (DKK 30 MILLION) MILESTONE PAYMENT RELATED TO INITIATION OF PHASE 1 WITH LONG-ACTING AMYLIN ANALOG

* RESULTS ARE EXPECTED IN LATE 2018 ON BOTH COMPOUNDS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below